MIRA
INFORM REPORT
|
Report Date : |
17.09.2007 |
IDENTIFICATION DETAILS
|
Name : |
MASS PHARMA (PRIVATE) LIMITED |
|
|
|
|
Registered Office : |
515-A, |
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
1996 |
|
|
|
|
Com. Reg. No.: |
L-08588/19960502 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture & Marketing of Pharmaceutical Products |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
Business Name
MASS PHARMA (PRIVATE) LIMITED
Full Address
|
Registered Address |
|
515-A, |
|
Tel |
92 (42) 5168995, 5168996,
5164307, 5164308 |
|
Fax |
92 (42) 5162831 |
|
|
Short Description Of
Business
|
Nature of Business |
Manufacture & Marketing of Pharmaceutical Products |
|
Year Established |
1996 |
|
Registration # |
L-08588/19960502 |
Factory Location
|
Address |
17-KM, |
|
Tel # |
92 (42) 5824881, 5824882,
5824883, 5824884 |
|
Fax # |
92 (42) 5813747 |
Auditors
Nazir Chaudry & Co.
(Chartered
Accountants)
4th Floor, Burhani Centre,
Legal Status
Subject Company was incorporated as a Private Limited Company in 1996
|
Authorized Capital |
Rs. 25,000,000/-
divided into 2,500,000 shares of Rs. 10/- each |
|
Issued & Paid up Capital |
Rs. 24,800,000/- divided into 2,480,000 shares
of Rs. 10/- each |
Details of Directors
|
Names |
Nationality |
Occupation |
Designation |
|
Mr. Khawaja Mohammad Akram Mr. S.M. Yousaf Gul Mr. Khawaja Amjad Ali Mrs. Shamim Yousuf Mr. Khawaja Mohammad Aslam |
Pakistani Pakistani Pakistani Pakistani Pakistani |
Business Business Business Business Business |
Chief Executive Director Director Director Director |
Shareholders
|
Names of Shareholders |
Percentage of Shareholding (%) |
|
Mr. Khawaja Mohammad
Akram Mr. S.M. Yousaf Gul Mr. Khawaja Amjad Ali Mrs. Shamim Yousuf Mr. Khawaja Mohammad Aslam |
40 25 15 15 5 |
Associated Companies
(1) K.S. MAS,
Products
AMODIP, AMORIN, AMOTAC, ANASEF, ANGESIC, ASPIRIN, BACTIZONE, BIOPLUS-C, CLINTOL, DICLOBID, ECTOBAL, FLURBIN, GLIP, HAEMOLOK, HYOPEN, KARBATAN, LOCASALIC, MACLEXIN, MASIQUINE, MASPRIN, MAZIVIT,MAZIVIT M, MEDIVIRIN, MUSTEX, NAPROFAST, PEPTAC, PONGESIC, PROBASE, SMARTIN, TRUE-FEN
Number of Employees
215
Annual Sales Volume
|
Year |
In Pak Rupees |
|
2006 |
200,000,000/- (Estimated) |
Exporting Countries
Mainly to Gulf & African Countries
Annual Production
Volume
The capacity and production of the company’s plant is indeterminable
as it is multi-product and involves various processes of manufacture.
Distributors Network
In
Bankers
Habib Metropolitan Bank Limited,
Habib Bank Limited, Pakistan.(Mortgage obtained PKR 67,000,000/-)
Faysal Bank Limited,
Standard Chartered
Memberships
Foreign Exchange
Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 60.72 |
|
|
1 |
Rs. 121.60 |
|
Euro |
1 |
Rs. 84.00 |
Comments
Subject is a well-established company having fine track. Directors are reported as experienced and resourceful businessmen. Their trade relations are reported as fair. The Company can be considered for normal business dealings at usual trade terms and conditions.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)